Sabra Health CareSBRA.OValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Richly Valued” zone.
As of Oct 16, 2026, Sabra Health Care (SBRA.O) trades at a P/E of 75.00x, P/B of 1.80x, P/S of 5.75x, and a dividend yield of 4.66%.
Longitudinal percentile comparison: P/E sits at the 83rd percentile over the trailing 10Y window (vs. 79th percentile over 3Y); P/B sits at the 94th percentile over the trailing 10Y window (vs. 85th percentile over 3Y); P/S sits at the 41st percentile over the trailing 10Y window (vs. 36th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 92nd percentile within its industry and the 91st percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 4.66%, ranking at the 25th percentile over the trailing 20Y window.
Cross-checking P/E against P/B, the two percentiles sit within 11.2 points of each other — a consistent signal from both angles. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Sabra Health Care operates in the Finance, Insurance, And Real Estate sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: NASDAQ: SBRA · SBRA
Want the full picture on whether Sabra Health Care (SBRA.O) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 75.00 | ||||||
| P/B (MRQ) | 1.80 | ||||||
| P/S (TTM) | 5.75 | ||||||
| Dividend Yield | 4.66% | ||||||
| Buyback + Div Yield | 4.66% |